ABCL-298 Diffuse Large B-Cell Lymphoma During the Covid-19 Pandemic in Two Tertiary Centers: The Israeli/Italian Study

Introduction: The COVID-19 pandemic posed a major challenge in cancer care worldwide, which might have an impact on the management of hematologic malignancies. Aims: To compare the characteristics, management, and outcomes of diffuse large B-cell lymphoma (DLBCL) patients diagnosed during the first...

Descripción completa

Detalles Bibliográficos
Autores principales: Giladi, Odil, Bagnato, Gianmarco, Gentilini, Marianna, Shimony, Shai, Pasvolsky, Oren, Berger, Tamar, Itchaki, Gilad, Raanani, Pia, Broccoli, Alessandro, Stefoni, Vittorio Stefoni, Lolli, Ginevra, Argnani, Lisa, Zinzani, Pier Luigi, Gurion, Ronit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Aggressive B-Cell Lymphoma
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489237/
http://dx.doi.org/10.1016/S2152-2650(22)01524-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489237/
http://dx.doi.org/10.1016/S2152-2650(22)01524-5

Ejemplares similares